Goodolol XL AM 50 Tablet is a combination antihypertensive medication containing Amlodipine 5 mg and Metoprolol Succinate 50 mg, designed for the management of hypertension and related cardiovascular conditions. Amlodipine, a dihydropyridine calcium channel blocker, acts by inhibiting calcium ion influx into vascular smooth muscle and cardiac muscle, resulting in vasodilation and reduced peripheral resistance. Metoprolol Succinate, a beta-1 selective adrenergic blocker, decreases heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and reducing myocardial oxygen demand. The extended-release formulation of Metoprolol Succinate ensures sustained plasma concentration, facilitating once-daily dosing and improved patient compliance. Goodolol XL AM 50 is indicated for the treatment of essential hypertension, angina pectoris, and for secondary prevention following myocardial infarction. The combination therapy offers synergistic effects by targeting different mechanisms involved in blood pressure regulation, enhancing therapeutic efficacy while minimizing adverse effects. Common side effects may include dizziness, fatigue, headache, and peripheral edema. Caution is advised in patients with bradycardia, heart block, or severe hepatic impairment. Regular monitoring of blood pressure and heart rate is recommended during therapy. This medication should be used under medical supervision with adherence to prescribed dosage and contraindications.